WP Perspectives – Jan. 18, 2022

Perspectives Jan 18 cover

Focus on Facts

  • The Biden administration's plan to send 1 billion at-home tests to Americans for free is an historic undertaking, but will take weeks or months to fully execute….contracts to fulfill the pledge are expected to be awarded in the next two weeks. People should be able to order up to 4 tests starting Wednesday, Jan. 19 by visiting covidtests.gov with delivery within 7-12 days.

    covid home test

 

  • Private insurers must pay for up to eight at-home rapid tests per person, per month, the Biden administration said. But supplies are still low. That plan was set to take effect last Saturday. The rules encourage health plans to set up a network of preferred pharmacies, stores and other business through which people in the plan can get tests without paying anything out of pocket. People should check with their health insurance provider to find out how the process works and how to get reimbursed. “While there will likely be some hiccups in early days, we will work with the administration to swiftly address issues as they arise,” Matt Eyles, president of America’s Health Insurance Plans, said. Washington Post

 

  • Know what you are getting. The FDA has a list of COVID-19 test kits that are approved for use in the U.S. and advises consumers to stop using one company’s antigen and antibody tests due to inadequate performance and the high risk of false results. The warning claims the LuSys Laboratories COVID-19 Antigen Test (Nasal/Saliva) and the LuSys Laboratories COVID-19 IgG/IgM Antibody Test have not been authorized or approved for distribution or use in the U.S. The tests, believed to have been distributed for use in laboratories or for at-home testing, are currently being sold under the company name Luscient Diagnostics or Vivera Pharmaceuticals, or with the trade name EagleDx.
  • In November, over 2 million at-home COVID-19 tests were recalled by manufacturer Ellume due to the potential for false-positive results. Nextstar/FDA.gov

News You Can Use

  • With the Supreme Court’s 6-3 decision to block the US government’s vaccine mandate for large American employers, a key tool to drive vaccination numbers is lost at a time when they are stalling. . . “Without a wide-reaching federal mandate, it’s unlikely the national vaccination rate of just over 60% will improve,” said public health law expert Lawrence Gostin. With no other incentives meaningfully moving the needle on vaccine uptake, the court's decision means the US is “likely reaching the end of the road on new vaccinations,” reports Axios. The court did uphold a vaccination requirement for health care employees, which will affect 17 million Americans—but could further hurt health worker shortages in rural areas with low vaccination rates.
  • Key Take Away: It is more important than ever that the vaccination effort continues on the local level.
  • Moderna expects to report vaccine trial data for children aged 2-5 in March.
  • The COVID generation: how is the pandemic affecting kids’ brains?  Presbyterian Morgan Stanley Children’s Hospital in New York City had more than two years of data on infant development; since late 2017, they had been analyzing the communication and motor skills of babies up to six months old. Pediatrician Dani Dumitriu thought it would be interesting to compare the results from babies born before and during the pandemic. The observations were that some babies born during the past two years might be experiencing developmental delays, whereas others might have thrived, if carers were at home for extended periods and there were more opportunities for siblings to interact. As with many aspects of health during the pandemic, social and economic disparities have a clear role in who is affected the most. This article in Nature describes the study in more detail.
  • Key Take Away: the more interaction, the greater the development.

COVID-cabulary

Super immunity”

Super immunity is the idea that someone who is fully vaccinated against COVID-19 and gets a breakthrough infection will be extremely well protected against the virus going forward. Early studies suggest there is enhanced immunity, but with a virus that’s constantly mutating in hard-to-predict ways, there’s much to be seen about how “super” the immunity is. Don't count on it, and continue the prevention and mitigation efforts.

Deltacron

Researchers in Cyprus believe they’ve identified COVID-19 infections combining the omicron and delta variants. You knew it was coming. 😉

Beware the scam!

dollar bill with mask

Criminals are using the full suite of scam tools — phishing emails and texts, bogus social media posts, robocalls, impostor schemes and more — and closely following the headlines, adapting their messages and tactics as new medical and economic issues arise. In addition to the false claims you've become accustomed to, scammers are offering fake tests and bogus cures – even hawking Viagra, and a blend of Benadryl and milk as remedies for COVID. AARP has published an article about the latest attempts to separate people from their money: https://www.aarp.org/money/scams-fraud/info-2020/coronavirus.html

The Epi-Center

Epidemiology is the science at center of public health. 

disposable mask

 

Masking.  Ideally, according to the CDC, you should wear a N95 or a KN95 mask for the best protection. But if that isn't an option, consider the following from an article on Nexstar:

Have you ever found yourself with only one mask option – wearing a disposable you’ve already worn once before? Maybe you had it in your jacket pocket or in your car’s cup holder. But should you really be wearing a disposable mask more than once?

There is no “true, hard and fast rule,” for wearing disposable masks, said Chris Sulmonte, a project administrator for the Johns Hopkins Bio-Containment Unit. Instead, you should take into account two main factors.

First, evaluate the fit of the mask. Any mask, whether it’s a KN95, a light blue disposable, or a reusable mask, should fit well. If the ear loops are starting to expand or stretch, or there are gaps developing on the side or around the mask, it’s time to replace the mask.

Second is the material of the mask itself and the wear-and-tear it has experienced. If the mask appears worn out or discolored, you should change it out. How the mask was previously worn matters – there’s a big difference between a mask worn to an uncrowded store for light shopping and one used to work out.

“That [lightly-used] mask doesn’t have a lot of residue inside of it, a lot of sweat, things that break down the material or thin it out,” Sulmonte says. But if you take that same mask, wear it at the gym for a 60-minute workout and sweat in it, it’s best to not re-wear that mask. “A lot of times you will see some discoloration, you’ll see a lot of moisture inside of there, you’ll start to see the material and it’ll start to wear out a little bit. That’s probably a good time to change that out.”

If you’re wearing a reusable mask, you can treat them like clothing. “It’s the same thing that you have with a T-shirt,” he explains. “You can tell the difference when the shirt has been used and when you should probably have it cleaned.” If your reusable mask doesn’t feel fresh or appears worn out, it’s time to wash it.

If you’re leaving a mask in your car, gym bag, or anywhere else for easy access, Sulmonte recommends storing it in a paper or plastic bag. Because there will always be moisture on a mask after you wear it, Sulmonte notes the bag should be able to stay open, allowing the mask to air out.

Overall, Sulmonte says the most important features of a mask are that it fits well and it has multiple layers.

“Those are really the most important pieces. So if you’re able to do that for most of the situations you’re going to run into, that’s going to be providing protection that you’re looking for.”

COVID-19 Data

Franklin County
Henry County
Martinsville
Patrick County

https://www.vdh.virginia.gov/coronavirus

Cases

8,442
8,712
2,669
2,816

Hospitalizations

311
491
190
140

Deaths

134
212
100
72
cumulative total
as of 01/14/22

% Fully Vaxed & Boosted/3rd Dose

49.4  &  21.9
50.1  &  21
59.6  &  20.9
41.7  &  18.8

cumulative total as of 01/15/22